Apotex Health Corp (APTX.TO) has seen mixed performance recently amid significant corporate developments.
This week, Apotex Health Corp's stock closed at C$33.20, reflecting a modest increase of 1.44% on the day. However, over the past week, the stock has dipped slightly by 0.82%. Year-to-date, shares have performed well, up 23.16%, but the recent month has seen a decline of 7.33%.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeMarket cap
$7.43B
52W high
$40.11
52W low
$26.01
1W change
+5.21%
Analyst Price Targets
Based on analyst covering APTX · as of Sep 23, 2026
Wall Street analysts forecast APTX stock price to rise 27.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.37
+27.3% Upside
Previously C$41.23 on Sep 17, 2026
Current Price
C$32.50
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
46.1%
Annualized
90-Day Vol
45.8%
Annualized
Trend (90d)
-32.2%
Annualized drift
90d Mean
C$29.62
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$31.98 | C$27.28 – C$37.49 |
| 60 trading days | C$30.77 | C$24.58 – C$38.54 |
| 90 trading days | C$29.62 | C$22.48 – C$39.01 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider the recent performance trends alongside the company's strategic developments, which may influence future growth prospects.
C$33.20 - Last Close
The stock is currently trading at 51% of its 52-week range, indicating potential volatility.
Bull case
The company has reported positive financial results, showing an 11% revenue growth in Canada for Q1 2027. Additionally, it has secured a BBB (low) investment-grade rating, which highlights its financial stability and potential for future growth.
Bear case
Despite the positive news, the stock's recent decline and a negative profit margin of -0.9% may raise concerns about ongoing profitability and operational efficiency.
Recent Price Action
Advertisement
This week, Apotex Health Corp's stock closed at C$33.20, up 1.44% from the previous day. Despite this gain, the stock has experienced a slight weekly decline of 0.82%. Over the past month, shares are down 7.33%, although they have performed well year-to-date, showing an increase of 23.16%.
Corporate Developments
Apotex has been active in recent months with several key developments that may impact its stock performance. Notably, the company announced its financial results for Q1 2027 on August 12, 2026, reporting an 11% revenue growth in Canada and an adjusted EBITDA of $259 million with a 31% margin. Additionally, on July 16, 2026, Apotex received a BBB (low) investment-grade rating from Morningstar DBRS, enhancing its financial credibility. The company also completed a strategic transaction with Cumberland Pharmaceuticals on July 1, 2026, integrating their U.S. branded businesses into Apotex.
Technical Picture
As of the last close, Apotex's stock is trading below its 50-day moving average of C$34.61 and its 200-day moving average of C$34.46, indicating a potential bearish trend. The stock has a beta of 0.83, suggesting lower volatility compared to the broader market. The latest trading volume was 37,334 shares, significantly below the 20-day average volume of 338,652 shares, indicating reduced trading activity.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
